These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 5348467)

  • 21. Supersensitivity to catecholamines after impairment of extraneuronal uptake or catechol-O-methyl transferase.
    Trendelenburg U; Graefe KH
    Fed Proc; 1975 Sep; 34(10):1971-4. PubMed ID: 169167
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of desmethylimipramine, metanephrine and normetanephrine on the neuronal and extraneuronal accumulation of catecholamines in fish spleen.
    Ungell AL
    Acta Physiol Scand; 1986 May; 127(1):27-31. PubMed ID: 3728044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in the incidence and duration of ventricular fibrillation in dependence on the extraneuronal accumulation of isoprenaline in the perfused rat heart.
    Sono K; Kurahashi K; Fujiwara M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Oct; 331(1):76-81. PubMed ID: 4069232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of alpha-methyltyramine by the noradrenaline uptake process in the isolated rat heart.
    Iversen LL
    J Pharm Pharmacol; 1966 Aug; 18(8):481-4. PubMed ID: 4381852
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of inhibition of catechol-O-methyl transferase or of monoamine oxidase on the extraneuronal metabolism of 3H-(-)-noradrenaline in the rat heart.
    Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):285-92. PubMed ID: 6514013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uptake and metabolism of 3H-(+/-)-noradrenaline in the isolated perfused rat liver.
    Steinberg P; Acevedo C; Masana MI; Rubio MC
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):392-6. PubMed ID: 3405314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The outward transport of catecholamines mediated by uptake2 of the rat heart.
    Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Sep; 330(3):203-11. PubMed ID: 4058599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differences in the uptake, storage and metabolism of (+)- and (-)-noradrenaline.
    Iversen LL; Jarrott B; Simmonds MA
    Br J Pharmacol; 1971 Dec; 43(4):845-55. PubMed ID: 5152031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drug-induced changes in the release of ( 3 H)-noradrenaline from field stimulated rat iris.
    Farnebo LO; Hamberger B
    Br J Pharmacol; 1971 Sep; 43(1):97-106. PubMed ID: 5136468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The substrate specificity of uptake2 in the rat heart.
    Grohmann M; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):164-73. PubMed ID: 6527704
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disprocynium24, a novel inhibitor of the extraneuronal monoamine transporter, has potent effects on the inactivation of circulating noradrenaline and adrenaline in conscious rat.
    Eisenhofer G; McCarty R; Pacak K; Russ H; Schömig E
    Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):287-94. PubMed ID: 8878058
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Release of endogenous noradrenaline from an isolated muscular artery. Release of endogenous noradrenaline from an isolated muscular artery.
    Bell C; Vogt M
    J Physiol; 1971 Jun; 215(2):509-20. PubMed ID: 4336047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereoselectivity of extraneuronal uptake of catecholamines in rabbit aorta.
    Henseling M
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Dec; 328(2):219-20. PubMed ID: 6527708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of extraneuronal uptake inhibitors on the positive chronotropic response to isoprenaline and on the accumulation of isoprenaline in perfused rat heart after inhibition of catechol-O-methyl transferase.
    Magaribuchi T; Hama T; Kurahashi K; Fujiwara M
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Feb; 335(2):123-8. PubMed ID: 3561526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of delta1-tetrahydrocannabinol on the uptake of [3H]-(minus)-noradrenaline by the isolated perfused heart of the rat.
    Graham JD; Lewis MJ; Li DM
    Br J Pharmacol; 1974 Jul; 51(3):465-6. PubMed ID: 4451760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors involved in maintenance of cardiac catecholamine content: relative importance of synthesis and re-uptake.
    Bhagat B; Friedman E
    Br J Pharmacol; 1969 Sep; 37(1):24-33. PubMed ID: 4390484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuronal and extraneuronal uptake and efflux of catecholamines in the isolated rabbit heart.
    Lindmar R; Löffelholz K
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 284(1):63-92. PubMed ID: 4279349
    [No Abstract]   [Full Text] [Related]  

  • 38. An electron microscope autoradiographic study of the neuronal and extraneuronal localization of labeled amine in the heart of the bat after administration of tritiated norepinephrine.
    Gershon MD; Hagopian M; Nunez EA
    J Cell Biol; 1974 Sep; 62(3):610-24. PubMed ID: 4152772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The force driving the extraneuronal transport mechanism for catecholamines (uptake2).
    Schömig E; Babin-Ebell J; Russ H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Apr; 345(4):437-43. PubMed ID: 1620244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of debrisoquin (Declinax) on adrenergic function and norepinephrine metabolism.
    Horst WD; Gattanell P
    Biochem Pharmacol; 1970 Jul; 19(7):2335-41. PubMed ID: 5520376
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.